{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Period+A&page=42", "query": { "intervention": "Period A", "page": 42 }, "page_size": 10 }, "pagination": { "page": 42, "page_size": 10, "total_count": 12646, "total_pages": 1265, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Period+A&page=43&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Period+A&page=41&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-06T10:41:52.799Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00680342", "title": "Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Hepatitis C" ], "interventions": [ { "name": "Silymarin", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Center for Complementary and Integrative Health (NCCIH)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 154, "start_date": "2008-04", "completion_date": "2011-01", "has_results": false, "last_update_posted_date": "2013-03-18", "last_synced_at": "2026-11-06T10:41:52.799Z", "location_count": 5, "location_summary": "Boston, Massachusetts • Chapel Hill, North Carolina • Philadelphia, Pennsylvania + 1 more", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00680342" }, { "nct_id": "NCT03811873", "title": "Assessment of Vertebral Fracture Risk for First Time Liver Transplant Candidates", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Metabolic Bone Disease", "Transplant-Related Disorder", "Secondary Osteoporosis" ], "interventions": [ { "name": "Dual x-ray absorptiometry", "type": "DIAGNOSTIC_TEST" }, { "name": "Vertebral Fracture Assessment", "type": "OTHER" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 52, "start_date": "2019-02-18", "completion_date": "2022-08-30", "has_results": false, "last_update_posted_date": "2023-05-06", "last_synced_at": "2026-11-06T10:41:52.799Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03811873" }, { "nct_id": "NCT01658579", "title": "Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime Insulin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "HOE901-U300 (new formulation of insulin glargine)", "type": "DRUG" }, { "name": "Lantus (insulin glargine)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 59, "start_date": "2012-08", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2015-06-01", "last_synced_at": "2026-11-06T10:41:52.799Z", "location_count": 3, "location_summary": "Temecula, California • Minneapolis, Minnesota • Portland, Oregon", "locations": [ { "city": "Temecula", "state": "California" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT01658579" }, { "nct_id": "NCT02098096", "title": "Negative Work Exercise for the Treatment of Knee Arthritis", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteoarthritis", "Arthritis" ], "interventions": [ { "name": "Negative Work", "type": "OTHER" }, { "name": "Stretching", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Washington D.C. Veterans Affairs Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "70 Years", "sex": "MALE", "summary": "50 Years to 70 Years · Male only" }, "enrollment_count": 54, "start_date": "2014-03", "completion_date": "2019-11", "has_results": false, "last_update_posted_date": "2018-09-20", "last_synced_at": "2026-11-06T10:41:52.799Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02098096" }, { "nct_id": "NCT07193862", "title": "Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Colorectal Cancer Metastatic" ], "interventions": [ { "name": "Doxorubicin, FOLFOX, Botensilimab, Balstilimab, Bevacizumab, FOLFIRI, FOLFIRINOX, AGEN2373", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2025-12-10", "completion_date": "2028-04-15", "has_results": false, "last_update_posted_date": "2026-06-24", "last_synced_at": "2026-11-06T10:41:52.799Z", "location_count": 2, "location_summary": "Lake Success, New York • New Hyde Park, New York", "locations": [ { "city": "Lake Success", "state": "New York" }, { "city": "New Hyde Park", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07193862" }, { "nct_id": "NCT06682520", "title": "Evaluation of a Health System Integrated Model for Postpartum Education and Support in Rural Populations", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Health Care Utilization" ], "interventions": [ { "name": "Postpartum NEST-Rural Program (Hospital based service model)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 1300, "start_date": "2024-12-04", "completion_date": "2029-10", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-11-06T10:41:52.799Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06682520" }, { "nct_id": "NCT06669624", "title": "Resilience Through Interventions for Successful Early Outcomes", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Parenting Intervention", "Stress", "Caregiver Child Relationship", "Child Behavior Problem", "Mental Health" ], "interventions": [ { "name": "Attachment and Biobehavioral Catch-up (ABC)", "type": "BEHAVIORAL" }, { "name": "Waitlist with 4-month delay, then ABC", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2024-11-12", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2026-02-02", "last_synced_at": "2026-11-06T10:41:52.799Z", "location_count": 1, "location_summary": "Chapel Hill, South Carolina", "locations": [ { "city": "Chapel Hill", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06669624" }, { "nct_id": "NCT00819780", "title": "PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colon Cancer", "Colorectal Cancer", "Rectal Cancer", "Metastatic Colorectal Cancer" ], "interventions": [ { "name": "Panitumumab", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" }, { "name": "mFOLFOX6", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 285, "start_date": "2009-04-24", "completion_date": "2016-07-07", "has_results": true, "last_update_posted_date": "2022-12-06", "last_synced_at": "2026-11-06T10:41:52.799Z", "location_count": 63, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Berkeley, California + 59 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Berkeley", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Burbank", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00819780" }, { "nct_id": "NCT02617342", "title": "Robot-Mediated Intervention for Children With Autism Spectrum Disorders", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Autism Spectrum Disorder" ], "interventions": [ { "name": "Robot-mediated Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Hugo W. Moser Research Institute at Kennedy Krieger, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "8 Years", "sex": "ALL", "summary": "4 Years to 8 Years" }, "enrollment_count": 40, "start_date": "2015-11", "completion_date": "2018-02-01", "has_results": false, "last_update_posted_date": "2025-09-19", "last_synced_at": "2026-11-06T10:41:52.799Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02617342" }, { "nct_id": "NCT04766996", "title": "PROUD Study - Preventing Opioid Use Disorders", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Anesthesia", "Opioid Use" ], "interventions": [ { "name": "Guided mindfulness exercises", "type": "BEHAVIORAL" }, { "name": "Self-administered aromatherapy", "type": "OTHER" }, { "name": "Baby aspirin", "type": "DRUG" }, { "name": "Tylenol/Acetaminophen", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Meloxicam", "type": "DRUG" }, { "name": "Prilosec", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Voltaren", "type": "DRUG" }, { "name": "Zofran", "type": "DRUG" }, { "name": "Pepcid", "type": "DRUG" }, { "name": "Reglan", "type": "DRUG" }, { "name": "Versed", "type": "DRUG" }, { "name": "Lidocaine", "type": "DRUG" }, { "name": "Propofol", "type": "DRUG" }, { "name": "Ancef", "type": "DRUG" }, { "name": "Tranexamic Acid (TXA)", "type": "DRUG" }, { "name": "Decadron", "type": "DRUG" }, { "name": "Bupivacaine hydrochloride", "type": "DRUG" }, { "name": "Toradol", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "OTHER", "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 57, "start_date": "2021-05-17", "completion_date": "2021-12-27", "has_results": true, "last_update_posted_date": "2023-06-22", "last_synced_at": "2026-11-06T10:41:52.799Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04766996" } ] }